Clinical Research Directory
Browse clinical research sites, groups, and studies.
Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial
Sponsor: George Washington University
Summary
The goal of this clinical trial is to compare two health system-based approaches for offering kidney failure treatment options to older patients with kidney failure, specifically, to ensure patients are actively involved in a shared decision making (SDM) process covering a full range of treatment choices and have meaningful access to that full range of choices. These include standard in-center or home dialysis as well as alternative treatment plans (ATPs): active medical care without dialysis, time-limited trial of dialysis, palliative dialysis, and deciding not to decide. Approach 1 - Educate and Engage: Nephrology practices encourage their patients to a) participate in a kidney disease education program providing a balanced presentation of all options including ATPs, b) use evidence-based patient decision aids that include ATPs, and c) engage in SDM with staff trained in communication skills and best practices. Approach 2 - Educate and Engage Plus Kidney Supportive Care Program: Nephrology practices add a primary palliative care program to support patients who choose ATPs and their families. The program provides care coordination, symptom management, advance care planning, and psychosocial support to supplement usual care from their nephrologist. To compare the two approaches, the investigators will conduct a repeated, cross-sectional stepped wedge cluster randomized trial involving 20-25 chronic kidney disease clinics at 8 practice organizations around the United States. Aim 1: Compare the effectiveness of Approaches 1 and 2 in a) increasing proportion of patients choosing ATP and b) reducing patient-reported decisional conflict about treatment. Aim 2: Compare the patient and family experience of ATP care between Approaches 1 and 2 in terms of quality of life, services used, and end of life (EOL) experience. Aim 2a will focus on experience while patients are receiving an ATP. Aim 2b will describe the EOL experience. Aim 3: Evaluate implementation of each approach through a mixed-methods design based on the expanded RE-AIM framework. For Aims 1 and 2, researchers will collect information by chart review and surveys with patients and caregivers. For Aim 3, clinic administrators, clinical providers, and staff will complete pre- and post-test surveys at the beginning and end of each training.
Official title: Improving Shared Decision-Making and Access to Non-Dialytic Treatment for People With Kidney Disease (The ExPAND Trial)
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
3000
Start Date
2024-11-13
Completion Date
2028-06-01
Last Updated
2025-07-18
Healthy Volunteers
No
Conditions
Interventions
Educate and Engage
Nephrology practices implement a bundle in which they will encourage their patients to a) participate in a kidney disease education program providing a balanced presentation of all options including ATPs, b) use evidence-based patient decision aids that include ATPs, and c) engage in shared decision-making with staff who have been trained in communication skills and best practices.
Educate and Engage Plus Kidney Supportive Care Program
In addition to bundle described under "Educate and Engage," nephrology practices offer a systematic program integrating primary palliative care to support patients and their families who choose any ATP. The program closely follows patients and their families on ATP with care coordination, symptom management, advance care planning, and psychosocial support to supplement usual care from their nephrologist.
Locations (25)
UCSF/Zuckerberg San Francisco General Hospital and Trauma Center-Nephrology
San Francisco, California, United States
Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
Southeast Kidney Associates
Canton, Georgia, United States
Southeast Kidney Associates
East Point, Georgia, United States
St. Clair Nephrology
Shelby, Michigan, United States
The Rogosin Institute Manhattan Eat Dialysis
New York, New York, United States
Clinical Renal Associates
Exton, Pennsylvania, United States
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States
Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, United States
Renal Disease Research Institute
Dallas, Texas, United States
Renal Disease Research Institute
Fort Worth, Texas, United States
Renal Disease Research Institute
Garland, Texas, United States
Renal Disease Research Institute
Irving, Texas, United States
North Texas Kidney Disease Associates
Lewisville, Texas, United States
Renal Disease Research Institute
McKinney, Texas, United States
Renal Disease Research Institute
McKinney, Texas, United States
Renal Disease Research Institute
Mesquite, Texas, United States
North Texas Kidney Disease Associates
North Richland Hills, Texas, United States
North Texas Kidney Disease Associates
Plano, Texas, United States
Renal Disease Research Institute
Plano, Texas, United States
Virginia Nephrology Group
Alexandria, Virginia, United States
Virginia Nephrology Group
Arlington, Virginia, United States
Virginia Nephrology Group
Fairfax, Virginia, United States
West Virginia University Medicine
Fairmont, West Virginia, United States
West Virginia University Medicine
Morgantown, West Virginia, United States